...
首页> 外文期刊>Vaccine >F4 (K88) fimbrial adhesin FaeG expressed in alfalfa reduces F4+ enterotoxigenic Escherichia coli excretion in weaned piglets
【24h】

F4 (K88) fimbrial adhesin FaeG expressed in alfalfa reduces F4+ enterotoxigenic Escherichia coli excretion in weaned piglets

机译:在苜蓿中表达的F4(K88)纤维粘附素FaeG降低了断奶仔猪的F4 +产肠毒素的大肠杆菌排泄

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Transgenic plants are attractive bioreactors to large-scale production of recombinant proteins because of their relatively low cost. This study reports for the first time the use of transgenic plants to reduce enterotoxigenic Escherichia coli (ETEC) excretion in its natural host species. The DNA sequence encoding the major subunit and adhesin FaeG of F4+ ETEC was transformed into edible alfalfa plants. Targeting of FaeG production to chloroplasts led to FaeG levels of up to 1% of the total soluble protein fraction of the transgenic alfalfa. Recombinant plant-produced FaeG (pFaeG) remained stable for 2 years when the plant material was dried and stored at room temperature. Intragastric immunization of piglets with pFaeG induced a weak F4-specific humoral response. Co-administration of pFaeG and the mucosal adjuvant cholera toxin (CT) enhanced the immune response against FaeG, reflected a better induction of an F4-specific immune response. In addition, the intragastric co-administration of CT with pFaeG significantly reduced F4+ E. coli excretion following F4+ ETEC challenge as compared with pigs that had received nontransgenic plant material. In conclusion, transgenic plants producing the FaeG subunit protein could be used for production and delivery of oral vaccines against F4+ ETEC infections.
机译:转基因植物由于其相对较低的成本而成为大规模生产重组蛋白的有吸引力的生物反应器。这项研究首次报道了使用转基因植物减少其天然宿主物种中肠毒素性大肠杆菌(ETEC)的排泄。将编码F4 + ETEC主要亚基和粘附素FaeG的DNA序列转化为可食用的苜蓿植物。 FaeG生产针对叶绿体的靶向导致FaeG含量高达转基因苜蓿总可溶性蛋白组分的1%。当植物材料干燥并在室温下保存时,重组的植物产生的FaeG(pFaeG)保持稳定2年。用pFaeG对仔猪进行胃内免疫诱导了弱的F4特异性体液反应。 pFaeG和粘膜佐剂霍乱毒素(CT)的共同给药增强了对FaeG的免疫反应,反映了对F4特异性免疫反应的更好诱导。此外,与接受非转基因植物材料的猪相比,CT与pFaeG的胃内共同给药显着降低了F4 + ETEC攻击后F4 +大肠杆菌的排泄。总之,可以将产生FaeG亚基蛋白的转基因植物用于生产和运送针对F4 + ETEC感染的口服疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号